1. Home
  2. OFLX vs ADAG Comparison

OFLX vs ADAG Comparison

Compare OFLX & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Omega Flex Inc.

OFLX

Omega Flex Inc.

N/A

Current Price

$23.40

Market Cap

266.9M

Sector

Industrials

ML Signal

N/A

Logo Adagene Inc.

ADAG

Adagene Inc.

N/A

Current Price

$1.72

Market Cap

222.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OFLX
ADAG
Founded
1975
2011
Country
United States
China
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
266.9M
222.2M
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
OFLX
ADAG
Price
$23.40
$1.72
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $9.91
AVG Volume (30 Days)
36.1K
★ 196.5K
Earning Date
10-28-2026
08-12-2026
Dividend Yield
★ 5.80%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.70
N/A
Revenue
★ $98,296,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$129.59
P/E Ratio
$33.50
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$23.34
$1.50
52 Week High
$37.92
$4.85

Technical Indicators

Market Signals
Indicator
OFLX
ADAG
Relative Strength Index (RSI) 35.93 31.30
Support Level N/A N/A
Resistance Level $27.16 $3.50
Average True Range (ATR) 1.11 0.26
MACD -0.21 -0.03
Stochastic Oscillator 4.78 0.94

Price Performance

Historical Comparison
OFLX
ADAG

About OFLX Omega Flex Inc.

Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

Share on Social Networks: